Phillip Schwartz

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Jerusalem, Israel
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Phillip Schwartz

Form 4 holding President of R&D, Director

Entera Bio Ltd.

Security class
Ordinary Shares, par value NIS 0.0000769 per share
Shares / value
607,410
Estimated value
$601,336
Report date
20 Jan 2022
Price
$0.9900
Ownership
Direct

Insider Reports Filed by Phillip Schwartz

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .